Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'APOLIPOPROTEIN C-III' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 128 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Katsuren, K; Tamura, T; Arashiro, R; Takata, K; Matsuura, T; Niikawa, N; Ohta, T
      Structure of the human acyl-CoA : cholesterol acyltransferase-2 (ACAT-2) gene and its relation to dyslipidemia

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
    2. Tomiyasu, K; Walsh, BW; Ikewaki, K; Judge, H; Sacks, FM
      Differential metabolism of human VLDL according to content of ApoE and ApoC-III

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    3. Bard, JM; Charles, MA; Juhan-Vague, I; Vague, P; Andre, P; Safar, R; Fruchart, JC; Eschwege, E
      Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity - The Biguanides and the Prevention of the Risk of Obesity (BIGPRO) 1 study

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    4. Yamamoto, M; Nakagawa-Ueta, H; Katoh, N; Oikawa, S
      Decreased concentration of serum apolipoprotein C-III in cows with fatty liver, ketosis, left displacement of the abomasum, milk fever and retained placenta

      JOURNAL OF VETERINARY MEDICAL SCIENCE
    5. Katoh, N
      In addition to the high-density lipoprotein fraction, apolipoprotein C-IIIis detected in chylomicrons and the very low-density lipoprotein fraction from serum of normolipidemic cows

      JOURNAL OF VETERINARY MEDICAL SCIENCE
    6. Kersten, S; Mandard, S; Escher, P; Gonzalez, FJ; Tafuri, S; Desvergne, B; Wahli, W
      The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism

      FASEB JOURNAL
    7. Dallongeville, J; Meirhaeghe, A; Cottel, D; Fruchart, JC; Amouyel, P; Helbecque, N
      Polymorphisms in the insulin response element of APOC-III gene promoter influence the correlation between insulin and triglycerides or triglyceride-rich lipoproteins in humans

      INTERNATIONAL JOURNAL OF OBESITY
    8. Bremer, J
      The biochemistry of hypo- and hyperlipidemic fatty acid derivatives: metabolism and metabolic effects

      PROGRESS IN LIPID RESEARCH
    9. Talmud, PJ; Berglund, L; Hawe, EM; Waterworth, DM; Isasi, CR; Deckelbaum, RE; Starc, T; Ginsberg, HN; Humphries, SE; Shea, S
      Age-related effects of genetic variation on lipid levels: The Columbia University BioMarkers Study

      PEDIATRICS
    10. Oliver, WR; Shenk, JL; Snaith, MR; Russell, CS; Plunket, KD; Bodkin, NL; Lewis, MC; Winegar, DA; Sznaidman, ML; Lambert, MH; Xu, HE; Sternbach, DD; Kliewer, SA; Hansen, BC; Willson, TM
      A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    11. Dana, SL; Hoener, PA; Bilakovics, JM; Crombie, DL; Ogilvie, KM; Kauffman, RF; Mukherjee, R; Paterniti, JR
      Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat

      METABOLISM-CLINICAL AND EXPERIMENTAL
    12. Campos, H; Perlov, D; Khoo, C; Sacks, FM
      Distinct patterns of lipoproteins with apoB defined by presence of apoE orapoC-III in hypercholesterolemia and hypertriglyceridemia

      JOURNAL OF LIPID RESEARCH
    13. Groenendijk, M; Cantor, RM; De Bruin, TWA; Dallinga-Thie, GM
      New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia

      JOURNAL OF LIPID RESEARCH
    14. Winegar, DA; Brown, PJ; Wilkison, WO; Lewis, MC; Ott, RJ; Tong, WQ; Brown, HR; Lehmann, JM; Kliewer, SA; Plunket, KD; Way, JM; Bodkin, NL; Hansen, BC
      Effects of fenofibrate on lipid parameters in obese rhesus monkeys

      JOURNAL OF LIPID RESEARCH
    15. Hsu, HC; Lee, YT; Yeh, HT; Chen, MF
      Effect of gemfibrozil on the composition and oxidation properties of very-low-density lipoprotein and high-density lipoprotein in patients with hypertriglyceridemia

      JOURNAL OF LABORATORY AND CLINICAL MEDICINE
    16. Groenendijk, M; De Bruin, TWA; Dallinga-Thie, GM
      Two polymorphisms in the apo A-IV gene and familial combined hyperlipidemia

      ATHEROSCLEROSIS
    17. Russo, GT; Meigs, JB; Cupples, LA; Demissie, S; Otvos, JD; Wilson, PWF; Lahoz, C; Cucinotta, D; Couture, P; Mallory, T; Schaefer, EJ; Ordovas, JM
      Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study

      ATHEROSCLEROSIS
    18. Starck, M; Schiele, F; Herbeth, B; Vincent-Viry, M; Beaud, B; Siest, G; Visvikis, S
      Apolipoproteins E and C-III in apo B- and non-apo B-containing lipoproteins in middle-aged women from the Stanislas cohort: effect of oral contraceptive use and common apolipoprotein E polymorphism

      ATHEROSCLEROSIS
    19. Groenendijk, M; Cantor, RM; Funke, H; Dallinga-Thie, GM
      Two newly identified SNPs in the APO AI-CIII intergenic region are strongly associated with familial combined hyperlipidaemia

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    20. Hubacek, JA; Waterworth, DM; Poledne, R; Pitha, J; Skodova, Z; Humphries, SE; Talmud, PJ
      Genetic determination of plasma lipids and insulin in the Czech population

      CLINICAL BIOCHEMISTRY
    21. Zhu, YJ; Bujo, H; Takahashi, K; Taira, K; Kobayashi, J; Koshikawa, H; Sasaki, Y; Kanoh, T; Saito, Y
      Severe hypertriglyceridemia with plasma inhibitory factor(s) on lipoprotein lipase activity in a patient with a common Ser(447)-Ter LPL mutation

      CLINICA CHIMICA ACTA
    22. Hertz, R; Sheena, V; Kalderon, B; Berman, I; Bar-Tana, J
      Suppression of hepatocyte nuclear factor-4 alpha by acyl-CoA thioesters ofhypolipidemic peroxisome proliferators

      BIOCHEMICAL PHARMACOLOGY
    23. Choudhury, AI; Chahal, S; Bell, AR; Tomlinson, SR; Roberts, RA; Salter, AM; Bell, DR
      Species differences in peroxisome proliferation; mechanisms and relevance

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    24. Choi, GR; Suh, SP; Song, JW; Kee, SJ; Shin, JH; Ryang, DW
      Genetic variation of the Apo Al-CIII-AIV gene cluster in hypertriglyceridemic patients with chronic renal failure undergoing hemodialysis

      JOURNAL OF KOREAN MEDICAL SCIENCE
    25. Yamamoto, M; Katoh, N
      Decreased apolipoprotein C-III concentration in the high-density lipoprotein fraction from calves inoculated with Pasteurella haemolytica and bovine herpes virus-1

      JOURNAL OF VETERINARY MEDICAL SCIENCE
    26. Fang, D; Liu, B
      Apolipoprotein C-III can specifically bind to hepatic plasma membranes

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    27. Tornero, F; Garcia-Garzon, A; Rincon, B; Prieto, S; Uson, J; Lozano, L
      Apolipoproteins C-II and C-III abnormalities in hyperlipidemic and normolipidemic patients with chronic renal failure

      NEFROLOGIA
    28. Kalderon, B; Mayorek, N; Berry, E; Zevit, N; Bar-Tana, J
      Fatty acid cycling in the fasting rat

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    29. Willson, TM; Brown, PJ; Sternbach, DD; Henke, BR
      The PPARs: From orphan receptors to drug discovery

      JOURNAL OF MEDICINAL CHEMISTRY
    30. Batal, R; Tremblay, M; Barrett, PHR; Jacques, H; Fredenrich, A; Mamer, O; Davignon, J; Cohn, JS
      Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects

      JOURNAL OF LIPID RESEARCH
    31. Holzl, B; Kraft, HG; Wiebusch, H; Sandhofer, A; Patsch, J; Sandhofer, F; Paulweber, B
      Two novel mutations in the lipoprotein lipase gene in a family with markedhypertriglyceridemia in heterozygous carriers: potential interaction with the polymorphic marker D1S104 on chromosome 1q21-q23

      JOURNAL OF LIPID RESEARCH
    32. Grundy, SM
      Cholesterol-lowering therapy in secondary prevention: Remaining issues

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    33. Havel, RJ; Frost, PH
      The role of non-high-density lipoprotein-cholesterol in evaluation and treatment of lipid disorders

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    34. Kardassis, D; Pardali, K; Zannis, VI
      SMAD proteins transactivate the human apoCIII promoter by interacting physically and functionally with hepatocyte nuclear factor 4

      JOURNAL OF BIOLOGICAL CHEMISTRY
    35. de Man, FHAF; de Beer, F; van der Laarse, A; Jansen, H; Leuven, JAG; Souverijn, JHM; Vroom, TFFP; Schoormans, SCM; Fruchart, JC; Havekes, LM; Smelt, AHM
      The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia ismediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding

      ATHEROSCLEROSIS
    36. Dallongeville, J; Meirhaeghe, A; Cottel, D; Fruchart, JC; Amouyel, P; Helbecque, N
      Gender related association between genetic variations of APOC-III gene andlipid and lipoprotein variables in northern France

      ATHEROSCLEROSIS
    37. Sedova, L; Kazdova, L; Seda, O; Krenova, D; Kren, V
      Rat inbred PD/Cub strain as a model of dyslipidemia and insulin resistance

      FOLIA BIOLOGICA
    38. Marcais, C; Bernard, S; Merlin, M; Ulhmann, M; Mestre, B; Rochet-Mingret, L; Revol, A; Berthezene, F; Moulin, P
      Severe hypertriglyceridaemia in Type II diabetes: involvement of apoC-III Sst-I polymorphism, LPL mutations and apo E3 deficiency

      DIABETOLOGIA
    39. Ye, SQ; Kwiterovich, PO
      Influence of genetic polymorphisms on responsiveness to dietary fat and cholesterol

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    40. Galton, DJ; Ferns, GAA
      Genetic markers to predict polygenic disease: a new problem for social genetics

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    41. Jong, MC; Hofker, MH; Havekes, LM
      Role of ApoCs in lipoprotein metabolism - Functional differences between ApoC1, ApoC2, and ApoC3

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    42. Jansen, H; Chu, G; Ehnholm, C; Dallongeville, J; Nicaud, V; Talmud, PJ
      The T allele of the hepatic lipase promoter variant C-480T is associated with increased easting lipids and HDL and increased preprandial and postprandial LpCIII : B - European Atherosclerosis Research Study (EARS) II

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    43. Aouizerat, BE; Allayee, H; Cantor, RM; Dallinga-Thie, GM; Lanning, CD; de Bruin, TWA; Lusis, AJ; Rotter, JI
      Linkage of a candidate gene locus to familial combined hyperlipidemia - Lecithin : cholesterol acyltransferase on 16q

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    44. Bailey, CJ
      New pharmacological approaches to glycemic control

      DIABETES REVIEWS
    45. Watts, GF; Dimmitt, SB
      Fibrates, dyslipoproteinaemia and cardiovascular disease

      CURRENT OPINION IN LIPIDOLOGY
    46. Fruchart, JC; Duriez, P; Staels, B
      Peroxisome proliferator-activated receptor-alpha activators regulate genesgoverning lipoprotein metabolism, vascular inflammation and atherosclerosis

      CURRENT OPINION IN LIPIDOLOGY
    47. Gervois, P; Torra, IP; Chinetti, G; Grotzinger, T; Dubois, G; Fruchart, JC; Fruchart-Najib, J; Leitersdorf, E; Staels, B
      A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity

      MOLECULAR ENDOCRINOLOGY
    48. Gervois, P; Chopin-Delannoy, S; Fadel, A; Dubois, G; Kosykh, V; Fruchart, JC; Najib, J; Laudet, V; Staels, B
      Fibrates increase human REV-ERB alpha expression in liver via a novel peroxisome proliferator-activated receptor response element

      MOLECULAR ENDOCRINOLOGY
    49. Hussain, SS; Buraiki, J; Dzimiri, N; Butt, AI; Vencer, L; Basco, MC; Khan, B
      Polymorphism in apoprotein-CIII gene and coronary heart disease

      ANNALS OF SAUDI MEDICINE
    50. Edvardsson, U; Alexandersson, M; von Lowenhielm, HB; Nystrom, AC; Ljung, B; Nilsson, F; Dahllof, B
      A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643

      ELECTROPHORESIS
    51. Hodis, HN; Mack, WJ; Krauss, RM; Alaupovic, P
      Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: Clinical aspects

      CLINICAL CARDIOLOGY
    52. Asset, G; Staels, B; Wolff, RL; Bauge, E; Madj, Z; Fruchart, JC; Dallongeville, J
      Effects of Pinus pinaster and Pinus koraiensis seed oil supplementation onlipoprotein metabolism in the rat

      LIPIDS
    53. Brown, PJ; Winegar, DA; Plunket, KD; Moore, LB; Lewis, MC; Wilson, JG; Sundseth, SS; Koble, CS; Wu, ZD; Chapman, JM; Lehmann, JM; Kliewer, SA; Willson, TM
      A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPAR alpha agonist with potent lipid-lowering activity

      JOURNAL OF MEDICINAL CHEMISTRY
    54. Edvardsson, U; Bergstrom, M; Alexandersson, M; Bamberg, K; Ljung, B; Dahllof, B
      Rosiglitazone (BRL49653), a PPAR gamma-selective agonist, causes peroxisome proliferator-like liver effects in obese mice

      JOURNAL OF LIPID RESEARCH
    55. Marcoux, C; Tremblay, M; Nakajima, K; Davignon, J; Cohn, JS
      Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients

      JOURNAL OF LIPID RESEARCH
    56. Ribalta, J; Girona, J; Vallve, JC; La Ville, AE; Heras, M; Masana, L
      Vitamin A is linked to the expression of the AI-CIII-AIV gene cluster in familial combined hyperlipidemia

      JOURNAL OF LIPID RESEARCH
    57. Mekki, N; Christofilis, MA; Charbonnier, M; Atlan-Gepner, C; Defoort, C; Juhel, C; Borel, P; Portugal, H; Pauli, AM; Vialettes, B; Lairon, D
      Influence of obesity and body fat distribution on postprandial lipemia andtriglyceride-rich lipoproteins in adult women

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    58. Reddy, S; Yang, WB; Taylor, DG; Shen, XQ; Oxender, D; Kust, G; Leff, T
      Mitogen-activated protein kinase regulates transcription of the ApoCIII gene - Involvement of the orphan nuclear receptor HNF4

      JOURNAL OF BIOLOGICAL CHEMISTRY
    59. Kee, F; Amouyel, P; Fumeron, F; Arveiler, D; Cambou, JP; Evans, A; Cambien, F; Fruchart, JC; Ducimetiere, P; Dallongeville, J
      Lack of association between genetic variations of apo A-I-C-III-A-IV gene cluster and myocardial infarction in a sample of European male: ECTIM study

      ATHEROSCLEROSIS
    60. Auwerx, J
      PPAR gamma, the ultimate thrifty gene

      DIABETOLOGIA
    61. Waterworth, DM; Ribalta, J; Nicaud, V; Dallongeville, J; Humphries, SE; Talmud, P
      ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests

      CIRCULATION
    62. Brewer, HB
      Hypertriglyceridemia: Changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease

      AMERICAN JOURNAL OF CARDIOLOGY
    63. HUANG W; SASAKI J; MATSUNAGA A; NANIMATSU H; MORIYAMA K; HAN H; KUGI M; KOGA T; YAMAGUCHI K; ARAKAWA K
      NOVEL HOMOZYGOUS MISSENSE MUTATION IN THE APO A-I GENE WITH APO A-I DEFICIENCY

      Arteriosclerosis, thrombosis, and vascular biology
    64. MUKHERJEE R; STRASSER J; JOW L; HOENER P; PATERNITI JR; HEYMAN RA
      RXR AGONISTS ACTIVATE PPAR-ALPHA-INDUCIBLE GENES, LOWER TRIGLYCERIDES, AND RAISE HDL LEVELS IN-VIVO

      Arteriosclerosis, thrombosis, and vascular biology
    65. Burnett, JR; Barrett, PHR; Vicini, P; Miller, DB; Telford, DE; Kleinstiver, SJ; Huff, MW
      The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    66. Hertz, R; Bar-Tana, J
      Peroxisome proliferator-activated receptor (PPAR) alpha activation and itsconsequences in humans

      TOXICOLOGY LETTERS
    67. PACKARD CJ
      OVERVIEW OF FENOFIBRATE

      European heart journal
    68. BJORKEGREN J; KARPE F; VITOLS S; TORNVALL P; HAMSTEN A
      TRANSIENT TRIGLYCERIDEMIA IN HEALTHY NORMOLIPIDEMIC MEN INCREASES CELLULAR PROCESSING OF LARGE VERY-LOW-DENSITY LIPOPROTEINS BY FIBROBLASTSIN-VITRO

      Journal of lipid research
    69. BISGAIER CL; ESSENBURG AD; BARNETT BC; AUERBACH BJ; HAUBENWALLNER S; LEFF T; WHITE AD; CREGER P; PAPE ME; REA TJ; NEWTON RS
      A NOVEL COMPOUND THAT ELEVATES HIGH-DENSITY-LIPOPROTEIN AND ACTIVATESTHE PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR

      Journal of lipid research
    70. AVIRAM M; ROSENBLAT M; BISGAIER CL; NEWTON RS
      ATORVASTATIN AND GEMFIBROZIL METABOLITES, BUT NOT THE PARENT DRUGS, ARE POTENT ANTIOXIDANTS AGAINST LIPOPROTEIN OXIDATION

      Atherosclerosis (Amsterdam)
    71. MARTIN G; SCHOONJANS K; STAELS B; AUWERX J
      PPAR-GAMMA ACTIVATORS IMPROVE GLUCOSE-HOMEOSTASIS BY STIMULATING FATTY-ACID UPTAKE IN THE ADIPOCYTES

      Atherosclerosis (Amsterdam)
    72. BRITES FD; BONAVITA CD; CLOES M; YAEL MJ; FRUCHART JC; CASTRO GR; WIKINSKI RW
      VLDL COMPOSITIONAL CHANGES AND PLASMA-LEVELS OF TRIGLYCERIDES AND HIGH-DENSITY-LIPOPROTEIN

      Clinica chimica acta
    73. STAELS B; DALLONGEVILLE J; AUWERX J; SCHOONJANS K; LEITERSDORF E; FRUCHART JG
      MECHANISM OF ACTION OF FIBRATES ON LIPID AND LIPOPROTEIN METABOLISM

      Circulation
    74. HADZOPOULOUCLADARAS M; LAVRENTIADOU SN; ZANNIS VI; KARDASSIS D
      TRANSACTIVATION OF THE APOCIII PROMOTER BY ATF-2 AND REPRESSION BY MEMBERS OF THE JUN FAMILY

      Biochemistry (Easton)
    75. SALAS J; JANSEN S; LOPEZMIRANDA J; ORDOVAS JM; CASTRO P; MARIN C; OSTOS MA; BRAVO MD; JIMENEZPEREPEREZ J; BLANCO A; LOPEZSEGURA F; PEREZJIMENEZ F
      THE SSTI POLYMORPHISM OF THE APOLIPOPROTEIN C-III GENE DETERMINES THEINSULIN-RESPONSE TO AN ORAL-GLUCOSE-TOLERANCE TEST AFTER CONSUMPTION OF A DIET RICH IN SATURATED FATS

      The American journal of clinical nutrition
    76. DAVIGNON J
      METHODS AND END-POINT ISSUES IN CLINICAL DEVELOPMENT OF LIPID-ACTING AGENTS WITH PLEIOTROPIC EFFECTS

      The American journal of cardiology
    77. FRUCHART JC; BREWER B; LEITERSDORF E; BROCHIER M; BROWN G; CALVO C; CARMENA R; CESKA R; LOYSOONG WC; DAVIGNON J; GOTTO A; GRUNDY S; HAMSTEN A; KEECH A; MATSUZAWA Y; PATCH JR; PAOLETTI R; RASLOVA K; SMIRNOV V; STEINER G; THOMPSON G; ZHU JR
      CONSENSUS FOR THE USE OF FIBRATES IN THE TREATMENT OF DYSLIPOPROTEINEMIA AND CORONARY HEART-DISEASE

      The American journal of cardiology
    78. LEFEBVRE AM; PEINADOONSURBE J; LEITERSDORF I; BRIGGS MR; PATERNITI JR; FRUCHART JC; FIEVET C; AUWERX J; STAELS B
      REGULATION OF LIPOPROTEIN METABOLISM BY THIAZOLIDINEDIONES OCCURS THROUGH A DISTINCT BUT COMPLEMENTARY MECHANISM RELATIVE TO FIBRATES

      Arteriosclerosis, thrombosis, and vascular biology
    79. SCHOONJANS K; MARTIN G; STAELS B; AUWERX J
      PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS, ORPHANS WITH LIGANDS ANDFUNCTIONS

      Current opinion in lipidology
    80. LATRUFFE N; VAMECQ J
      PEROXISOME PROLIFERATORS AND PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPARS) AS REGULATORS OF LIPID-METABOLISM

      Biochimie
    81. STAELS B; SCHOONJANS K; FRUCHART JC; AUWERX J
      THE EFFECTS OF FIBRATES AND THIAZOLIDINEDIONES ON PLASMA TRIGLYCERIDE-METABOLISM ARE MEDIATED BY DISTINCT PEROXISOME PROLIFERATOR ACTIVATEDRECEPTORS (PPARS)

      Biochimie
    82. ARNADOTTIR M; BERG AL; DALLONGEVILLE J; FRUCHART JC; NILSSONEHLE P
      ADRENOCORTICOTROPIC HORMONE LOWERS SERUM LP(A) AND LDL CHOLESTEROL CONCENTRATIONS IN HEMODIALYSIS-PATIENTS

      Kidney international
    83. ARNADOTTIR M
      PATHOGENESIS OF DYSLIPOPROTEINEMIA IN RENAL-INSUFFICIENCY - THE ROLE OF LIPOPROTEIN-LIPASE AND HEPATIC LIPASE

      Scandinavian journal of clinical & laboratory investigation
    84. FISHER RM; MILES JM; KOTTKE BA; FRAYN KN; COPPACK SW
      VERY-LOW-DENSITY LIPOPROTEIN SUBFRACTION COMPOSITION AND METABOLISM BY ADIPOSE-TISSUE

      Metabolism, clinical and experimental
    85. FROYLAND L; MADSEN L; VAAGENES H; TOTLAND GK; AUWERX J; KRYVI H; STAELS B; BERGE RK
      MITOCHONDRION IS THE PRINCIPAL TARGET FOR NUTRITIONAL AND PHARMACOLOGICAL CONTROL OF TRIGLYCERIDE-METABOLISM

      Journal of lipid research
    86. FREDENRICH A; GIROUX LM; TREMBLAY M; KRIMBOU L; DAVIGNON J; COHN JS
      PLASMA-LIPOPROTEIN DISTRIBUTION OF APOC-III IN NORMOLIPIDEMIC AND HYPERTRIGLYCERIDEMIC SUBJECTS - COMPARISON OF THE APOC-III TO APOE RATIO IN DIFFERENT LIPOPROTEIN FRACTIONS

      Journal of lipid research
    87. HAWKE RL; CHAPMAN JM; WINEGAR DA; SALISBURY JA; WELCH RM; BROWN A; FRANZMANN KW; SIGEL C
      POTENT HYPOCHOLESTEROLEMIC ACTIVITY OF NOVEL UREIDO PHENOXYISOBUTYRATES CORRELATES WITH THEIR INTRINSIC FIBRATE POTENCY AND NOT WITH THEIR ACAT INHIBITORY ACTIVITY

      Journal of lipid research
    88. BJORKEGREN J; HAMSTEN A; MILNE RW; KARPE F
      ALTERATIONS OF VLDL COMPOSITION DURING ALIMENTARY LIPEMIA

      Journal of lipid research
    89. DALLINGATHIE GM; TRIP MV; ROTTER JI; CANTOR RM; BU XD; LUSIS AJ; DEBRUIN TWA
      COMPLEX GENETIC CONTRIBUTION OF THE APO AI-CIII-AIV GENE-CLUSTER TO FAMILIAL COMBINED HYPERLIPIDEMIA - IDENTIFICATION OF DIFFERENT SUSCEPTIBILITY HAPLOTYPES

      The Journal of clinical investigation
    90. PETERS JM; HENNUYER N; STAELS B; FRUCHART JC; FIEVET C; GONZALEZ FJ; AUWERX J
      ALTERATIONS IN LIPOPROTEIN METABOLISM IN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA-DEFICIENT MICE

      The Journal of biological chemistry
    91. DALLONGEVILLE J; BAUGE E; LEBEL P; FRUCHART JC
      FAT INGESTION IS ASSOCIATED WITH INCREASED LEVELS OF APOC-III-CONTAINING AND APOE-B-CONTAINING LIPOPROTEIN PARTICLES IN HUMANS

      European journal of clinical investigation
    92. MAYOREK N; KALDERON B; ITACH E; BARTANA J
      SENSITIZATION TO INSULIN-INDUCED BY BETA,BETA'-METHYL-SUBSTITUTED HEXADECANEDIOIC ACID (MEDICA-16) IN OBESE ZUCKER RATS IN-VIVO

      Diabetes
    93. RIBALTA J; LAVILLE AE; GIRONA J; VALLVE JC; MASANA L
      LOW PLASMA VITAMIN-A CONCENTRATIONS IN FAMILIAL COMBINED HYPERLIPIDEMIA

      Clinical chemistry
    94. HONG SH; PARK WH; LEE CC; SONG JH; KIM JQ
      ASSOCIATION BETWEEN GENETIC VARIATIONS OF APO AL-CIII-AIV CLUSTER GENE AND HYPERTRIGLYCERIDEMIC SUBJECTS

      Clinical chemistry
    95. GALTON DJ
      GENETIC-DETERMINANTS OF ATHEROSCLEROSIS-RELATED DYSLIPIDEMIAS AND THEIR CLINICAL IMPLICATIONS

      Clinica chimica acta
    96. VERGNES L; TANIGUCHI T; OMORI K; ZAKIN MM; OCHOA A
      THE APOLIPOPROTEIN A-I C-III/A-IV GENE-CLUSTER - APOC-III AND APOA-IVEXPRESSION IS REGULATED BY 2 COMMON ENHANCERS/

      Biochimica et biophysica acta, L. Lipids and lipid metabolism
    97. LOPEZMIRANDA J; JANSEN S; ORDOVAS JM; SALAS J; MARIN C; CASTRO P; OSTOS MA; CRUZ G; LOPEZSEGURA F; BLANCO A; JIMENEZPEREPEREZ J; PEREZJIMENEZ F
      INFLUENCE OF THE SSTI POLYMORPHISM AT THE APOLIPOPROTEIN C-III GENE LOCUS ON THE PLASMA LOW-DENSITY-LIPOPROTEIN-CHOLESTEROL RESPONSE TO DIETARY MONOUNSATURATED FAT

      The American journal of clinical nutrition
    98. FUKUSHIMA N; YAMAMOTO K; OZAKI I; MIZUTA T; KAJIHARA S; SETOGUCHI Y; SAKAI T
      HEPATIC APOLIPOPROTEIN-A-I, APOLIPOPROTEIN-C-III AND APOLIPOPROTEIN-EMESSENGER-RNA EXPRESSIONS IN HUMAN PARENCHYMAL LIVER-DISEASES

      HEPATOLOGY RESEARCH
    99. MORIYAMA K; SASAKI J; TAKADA Y; MATSUNAGA A; FUKUI J; ALBERS JJ; ARAKAWA K
      A CYSTEINE-CONTAINING TRUNCATED APO A-I VARIANT ASSOCIATED WITH HDL DEFICIENCY

      Arteriosclerosis, thrombosis, and vascular biology
    100. TAYLOR DG; HAUBENWALLNER S; LEFF T
      CHARACTERIZATION OF A DOMINANT-NEGATIVE MUTANT FORM OF THE HNF-4 ORPHAN RECEPTOR

      Nucleic acids research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/08/20 alle ore 09:21:14